Montreux Growth Partners is focused on making growth capital investments in category-leading companies that are advancing health.
We focus on commercial stage companies with highly differentiated products, technologies, and services. At the time of investment, a company will typically have $5 to $50 million in annual revenue. We typically invest $10 to $20 million per company, and our capital often fuels product expansion and innovation, new market entry, and strategic acquisitions.
We have a cohesive team that works closely together across all aspects of the investment process, from diligence, to investment decisions, to portfolio management. Our team is complementary with unique operational, financial, and sector expertise. We leverage this expertise through active support of our investments.